Famotidin-akri

Roman name

Famotidin-Akri

The composition and the form of

Male Film-coated-1 tabl.famotidin-20 megawatts contour acheikova packing 10 pcs. ; Per bundle two cartons packaging.

Pharmacokinetics

Quickly and almost completely absorbed from the digestive tract. C_max determined after 2 h after administration. Linking plasma protein-20%. A small number of metabolized in the liver. T_1/2 - 2.5-4 hours Most of the displays with urine in an unmodified form.

Clinical pharmacology

After a single injection of the drug continues to 12-24 hours

Indications

Ulcers stomach illness and / or duodenal ulcers (treatment and prevention), symptomatic canker syndrome Zollinger-Ellison.

Pregnancy and lactation

Contraindicated. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, pregnancy, breast-feeding.

Side-Effects

Diarrhoea, constipation, dry mouth, loss of appetite, headache, dizziness, fatigue, skin rashes.

Patient interaction

Antatsida slow induction. Decreases ketokonazola removals.

Precautions

Before applying the product to rule out a malignant tumor in the digestive tract. Patients with acute violations of kidney function should be reduced doses.

Directory → Интермедианты → Gistaminergicakie funds → Gistaminolitiki → H_2-antigistaminne funds → Famotidin-akri